Brooks Laboratories Q1 Results
- BSE: 533543
- NSE: BROOKS
- ISIN: INE650L01011
- Sector: Major Drugs
BSE
65.94
1.72 (2.68%)
1.72 (2.68%)Volume1.16 K
Updated: Fri 4 Sep, 2026 | 15:16:51
NSE
661.85 (2.88%)
1.85 (2.88%)Volume12.92 K
Updated: Fri 4 Sep, 2026 | 15:28:01
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹22.96 Cr.(-10.00%)
- Operating Profit₹1.45 Cr.(-47.08%)
- Profit After Tax₹-1.79 Cr.(NA%)
- Operating Margin6.30%(-41.20%)
Note: Comparison is on YoY basis
Quarterly - Brooks Laboratories Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 21.51 | 19.94 | 7.87% | 18.05 | -5.55% |
| Depreciation/ Amortization | 0.42 | 0.41 | 0.63% | 0.40 | 5.97% |
| Operating Income | 1.45 | 0.27 | 445.78% | -0.12 | -47.08% |
| Net Income | -1.79 | 1.52 | 0.00% | -2.41 | 0.00% |
| Net Income Before Taxes | -1.79 | 1.52 | 0.00% | -2.41 | 0.00% |
| Other Operating Expenses Total | 4.20 | 3.26 | 28.81% | 2.27 | 48.85% |
| Total Revenue | 22.96 | 20.21 | 13.61% | 17.93 | -10.00% |
| Selling/ General/ Admin Expenses Total | 4.21 | 3.85 | 9.44% | 3.07 | 14.83% |
| Diluted Normalized EPS | -0.61 | 0.52 | 0.00% | -0.92 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.